All stock lists
Vericel Corp (NASDAQ:VCEL)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
43.04+0.51 (+1.20%)
Insider Score
––Not scored
VCEL Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
VCEL Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 77.46 M | 68.42 M | 92.92 M | 67.50 M | 63.24 M | 52.60 M |
| Revenue Growth (YoY) | 22.48 % | 30.09 % | 23.27 % | 16.58 % | 20.09 % | 2.57 % |
| Cost of Revenue | 21.05 M | 19.16 M | 19.79 M | 17.92 M | 16.63 M | 16.32 M |
| Gross Profit | 56.40 M | 49.27 M | 73.13 M | 49.59 M | 46.61 M | 36.27 M |
| SG&A Expense | 48.48 M | 49.23 M | 43.46 M | 39.82 M | 41.91 M | 41.80 M |
| R&D Expense | 7.49 M | 8.10 M | 7.25 M | 6.32 M | 6.73 M | 7.26 M |
| Operating Expenses | 55.97 M | 57.33 M | 50.71 M | 46.13 M | 48.64 M | 49.06 M |
| Operating Income | 434.00 K | -8.06 M | 22.41 M | 3.45 M | -2.03 M | -12.79 M |
| Pretax Income | 2.21 M | -6.30 M | 24.10 M | 5.07 M | -553.00 K | -11.25 M |
| Tax Provision | 0.00 | 0.00 | 859.00 K | 0.00 | 0.00 | 0.00 |
| Net Income | 2.21 M | -6.30 M | 23.24 M | 5.07 M | -553.00 K | -11.25 M |
| EPS (Basic) | 0.04 | -0.12 | 0.46 | 0.10 | -0.01 | -0.23 |
| EPS (Diluted) | 0.04 | -0.12 | 0.45 | 0.10 | -0.01 | -0.23 |
| Shares Outstanding | 50.92 M | 50.77 M | 50.59 M | 50.49 M | 50.37 M | 49.91 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.